How to Help Your Patients Find Oxtellar XR In Stock: A Provider's Guide

When epilepsy patients call your practice frustrated because they can't find Oxtellar XR at their pharmacy, your team needs a clear, efficient response protocol. This provider's guide compiles the most effective strategies for helping patients locate Oxtellar XR, navigate insurance barriers, and receive their medication without dangerous gaps in treatment.

Why Patients Struggle to Fill Oxtellar XR

Oxtellar XR is not on the FDA's official drug shortage list as of 2026, but providers frequently hear from patients who can't find it. The core reasons:

• Most retail pharmacies don't stock specialty brand-name anticonvulsants routinely due to lower turnover.
• Insurance plans may route Oxtellar XR through specialty pharmacy channels, not standard retail.
• Prior authorization requirements can delay access, particularly when payers prefer generic oxcarbazepine IR.
• The retail cash price of $500–$1,300/month can make uninsured patients hesitant to fill even when the medication is in stock.

Step 1: Direct Patients to a Known Dispensing Pharmacy

The most efficient intervention is sending the prescription directly to a pharmacy your office knows stocks Oxtellar XR. Consider identifying 1-2 local pharmacies — ideally hospital-affiliated or high-volume chain locations — that you can reliably direct patients to. Call your local pharmacy contacts to confirm they carry your most commonly prescribed AED strengths and keep that list updated in your EHR or practice management system.

Step 2: Leverage Supernus Support

Supernus Pharmaceuticals offers a comprehensive hub program — Supernus Support — that your practice can use to help patients access Oxtellar XR. Key services include:

• Benefits Investigation (BI): Determines coverage, copay requirements, and whether PA is needed.
• Prior Authorization support: Supernus Support coordinates PA requests and can use CoverMyMeds for streamlined electronic submission.
• Specialty pharmacy network: Patients can receive Oxtellar XR through Supernus-designated pharmacies with flexible delivery options.
• Patient Assistance Program: No-cost medication for qualifying uninsured or underinsured patients.

Reach Supernus Support at 1-866-398-0833 (Monday–Friday, 8:30 AM–5:30 PM ET). The enrollment form can be downloaded from oxtellarxr.com and faxed to 1-855-998-1515.

Step 3: Recommend medfinder for Patients Searching on Their Own

For patients who need to search independently, medfinder is a service that calls pharmacies near the patient's location to check which ones have Oxtellar XR available. The patient provides their medication, dosage, and ZIP code, and results are sent by text. This eliminates the need for patients to call pharmacies one by one and reduces the chance they'll go without medication due to frustration with the search process.

Step 4: Consider 90-Day Mail-Order for Established Patients

For patients on stable Oxtellar XR doses, transitioning to mail-order pharmacy (90-day supply) eliminates the monthly fill challenge. Most commercial insurance plans offer this option. Write 90-day prescriptions for stable patients and counsel them to initiate the mail-order fill well before running out. This is particularly important for patients who've experienced access difficulty in the past.

Step 5: Establish a Practice Protocol for Medication Access Calls

Consider training your front desk and medical assistant staff to handle Oxtellar XR access calls with a standard protocol:

1. Assess how many days of medication remain. Treat any patient with <3 days supply as urgent.
2. Refer to your practice's preferred dispensing pharmacies list and send the prescription directly if possible.
3. Escalate to the provider for same-day call-back if patient has <24 hours of medication left.
4. Document the call and access attempt in the patient chart.

Safety Counseling: The Critical Message for Every Patient

Every patient on Oxtellar XR should receive clear, documented counseling: never stop this medication abruptly. Per the FDA prescribing information, abrupt withdrawal of Oxtellar XR increases the risk of seizure frequency and status epilepticus. Reinforce this at every visit and include it in your patient discharge instructions.